Get the Stockscreener App
4.27
1.67%
0.07
Mimedx Group Inc stock is traded at $4.27, with a volume of 974.75K.
It is up +1.67% in the last 24 hours and up +1.67% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$4.20
Open:
$4.19
24h Volume:
974.75K
Relative Volume:
0.71
Market Cap:
$622.40M
Revenue:
$389.42M
Net Income/Loss:
$30.70M
P/E Ratio:
20.90
EPS:
0.2043
Net Cash Flow:
$67.23M
1W Performance:
-1.61%
1M Performance:
+1.67%
6M Performance:
-16.60%
1Y Performance:
-40.28%
1-Day Range:
$4.12
$4.315
1-Week Range:
$4.12
$4.39
52-Week Range:
$3.025
$7.97
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.86 | 2.83B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.89 | 388.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.88 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
5.45 | 348.74M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.03 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Initiated | Citizens | Mkt Outperform |
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - tradingkey.com
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx to buy Sanara MedTech (SMTI) in $350M cash-and-stock deal - Stock Titan
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - TradingView
MiMedx Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E - GuruFocus
MiMedx: Q2 Earnings Snapshot - Marietta Daily Journal
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside - GuruFocus
MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MiMedx Group Inc (MDXG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MiMedx Group Inc (MDXG) Institutional Confidence - tradingkey.com
MiMedx Group Inc (MDXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MiMedx Group Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MDXG|MiMedx Group Inc|Price:4.340|Chg%:+0.080 - TradingKey
Paradigm Capital Management Inc. NY Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group, Inc Revenue Breakdown – BOATS:MDXG - TradingView
MDXG|MiMedx Group Inc|Price:4.200|Chg%:+0.070 - TradingKey
MiMedx Group (MDXG) Expected to Announce Earnings on Wednesday - MarketBeat
MiMedx Group, Inc (MDXG) Investor Outlook: Exploring a 52.42% Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
MiMedx Group (NASDAQ:MDXG) Shares Up 0.7%Here's Why - MarketBeat
MIMEDX will review second-quarter results in a July 29 webcast - Stock Titan
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29 - GlobeNewswire
MiMedx Group (MDXG) Cantor Global Healthcare Conference 2025 Summary - Quartr
Form 4 MiMedx Group Inc For: 7 July By Investing.com - Investing.com Nigeria
MIMEDX (MDXG) CFO has shares withheld to cover RSU tax liability - Stock Titan
MiMedx Group, Inc.(NasdaqCM:MDXG) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 2500 Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell 2000 Value Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell Microcap Value Benchmark Index - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 2000 Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) dropped from Russell 3000E Growth Benchmark - marketscreener.com
MiMedx Group, Inc.(NasdaqCM: MDXG) added to Russell 2000 Value-Defensive Index - marketscreener.com
MDXGMimedx Group Inc Latest SEC Filings - Finviz
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):